Growth hormone and IGF-1 treatments carry risks, including increased cancer risk. — Whalespan
Growth hormone and IGF-1 treatments carry risks, including increased cancer risk.
⚠ High risk
We can't find evidence that holds up here. Proponents are reasoning from mechanism or analogy rather than direct human data, and the most credible skeptics raise objections we can't dismiss.
✕NOTSUPPORTED
⚠
High-risk intervention — consult a physician before acting.Drug-drug interactions, dose-dependence, and screening contraindications apply.
“And yet they also have problems because they can increase growth of small tumors that normally might be eliminated. So there is an increased cancer risk with growth hormone treatments and IGF-1 or anything that increases IGF-1 such as sermorelin or ipamorelin, any of the peptides that you hear about nowadays.”